References
- Adlercreuts H., Tenhunen R. Some aspects of the interaction between natural and synthetic female sex hormones and the liver. Am J Med 1970; 49: 630
- Alpert M. E., Hutt M. S. R., Davidson C. S. Hepatoma in Uganda. Lancet 1978; i: 1265
- Baum J. K., Bookstein J. J., Holtz F., Klein E. W. Possible association between benign hepatomas and oral contraceptives. Lancet 1973; ii: 926
- Berg J. W., Ketelarr R. J., Rose E. F., Vernon R. G. Hepatomas and oral contraceptives. Lancet 1974; ii: 349
- Christopherson W. M. Correspondance. Br Med J 1975; 4: 756
- Christopherson W. M., Mays E. T. Liver tumours and oral contraceptives. Lancet 1976; i: 1076
- Christopherson W. M., Mays E. T., Barrows G. Hepatocellular carcinoma in young women on oral contraceptives. Lancet 1978; ii: 38
- Clemmensen J. Statistical studies in malignant neoplasma V. Acta Path et Microbiol Scand Sect A Suppl 1977; 261
- Contostavlos D. L. Benign hepatomas and oral contraceptives. Lancet 1973; ii: 1200
- Davis M., Portmann B., Searle M., Wright R., Williams R. Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives. Br Med J 1975; 4: 496
- Edmonson H. A., Henderson B., Benton B. Liver-cell adenomas associated with use of oral contraceptives. New Eng J 1976; 9: 470
- Gall E. A. Primary and metastatic carcinoma of the liver. Arch Path 1960; 70: 226
- Gattanell P. N., Perloff M., Holland J. F. Hepatocellular carcinoma in a young woman with prolonged exposure to oral contraceptives. Med Ped Oncology 1978; 4: 99
- Glassberg A. B., Rosenbaum E. H. Oral contraceptives and malignant hepatoma. Lancet 1976; i: 479
- Ham J. M., Stevenson D., Liddelow A. G. Hepatocellular carcinoma possibly induced by oral contraceptives. Digestive Diseases 1978; 23: 38
- Hermann R. E., David T. E. Spontaneous rupture of the liver caused by hepatomas. Surgery 1973; 74: 715
- Horvath E., Kovacs K., Ross R. C. Ultrastructural findings in a well-differentiated hepatoma. Digestion 1972; 7: 74
- Johnson F. L., Lerner K. G., Siegel M., Feagler J. R., Majerus P. W., Hartmann J. R., Thomas E. D. Association of androgenicanabolic steroid therapy with development of hepatocellular carcinoma. Lancet 1972; ii: 1273
- Kay S., Schatzki P. F. Ultrastructure of a benign liver cell adenoma. Cancer 1971; 28: 755
- Klatskin G. Hepatic tumors: Possible relationship to use of oral contraceptives. Gastroenterology 1977; 73: 386
- Lin Tien-Yu. Primary cancer of the liver. Quadrennial review. Scand J Gastroenterology Suppl 1970; 6
- Mays E. T., Christopherson W. M., Mahr M. M., Williams H. C. Hepatic changes in young women ingesting contraceptive steroids. JAMA 1976; 235: 730
- Meyer P., LiVolsi V. A., Cornog J. L. Hepatoblastoma associated with an oral contraceptive. Lancet 1974; ii: 1387
- Moesner J., Baunsgaard P., Starklint H., Thommesen N. Focal hyperplasia of the liver. Acta Path Microbiol Scand Sect A 1977; 85: 113
- Nissen E. D., Kent D. R., Nissen S. E. Etiologic factors in the pathogenesis of liver tumors associated with oral contraceptives. Am J Obstet Gynecol 1977; 127: 61
- O'Sullivan J. P., Wilding R. P. Liver hamartomas in patients on oral contraceptives. Br Med J 1974; 3: 7
- Palmer P. E., Christopherson W. M., Wolfe H. J. Alpha antitrypsin, protein marker in oral contraceptive - associated hepatic tumors. Am J Clin Pathol 1977; 68: 736
- Parker J. C., Dahlin D. C., Stauffer M. H. Malignant hepatoma: Evaluation of surgical (including needle biopsy) material from 69 cases. Mayo Clin Proc 1970; 45: 25
- Reuber M. D. Effect of age and testosterone on the induction of hyperplastic nodules, carcinomas, and cirrhosis of the liver in rats ingesting N-2-Fluorenyldiacetamide. Europ J Cancer 1976; 12: 137
- Sherlock S. Hepatic adenomas and oral contraceptives. Gut 1975; 16: 753
- Thalassinos N. C., Lymberatos C., Hadjioannou J., Gardikas C. Liver-cell carcinoma after long-term oestrogen-like drugs. Lancet 1974; i: 270
- Tigano F., Ferlazzo B., Barrile A. Oral contraceptives and malignant hepatoma. Lancet 1976; ii: 196
- Winkler K., Poulsen H. Liver disease with periportal sinusoidal dilatation. A possible complication to contraceptive steroids. Scand J Gastroenterology 1975; 10: 699